LIPASE INHIBITORS


















- Percentages expressed as orlistat minus placebo
- Incidence observed with orlistat 120 mg three times a day
- Reference [10]
Side effect First year of use
(% of patients)
Second year of use
(% of patients)
Oily rectal spotting 25.3 4.2
Flatus with Discharge 22.5 1.9
Fecal Urgency 15.4 1.1
Fatty/Oily stool 17.1 4.9
Oily Evacuation 11.1 2.1
Increased defecation 6.7 1.8
Fecal Incontinence 6.8 1.6